Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distribute...

FDA Drug Recall #D-0020-2023 — Class II — September 30, 2022

Recall Summary

Recall Number D-0020-2023
Classification Class II — Moderate risk
Date Initiated September 30, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm AuroMedics Pharma LLC
Location East Windsor, NJ
Product Type Drugs
Quantity 11,520 units

Product Description

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

Reason for Recall

Subpotent Drug: Out of specification for assay

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot # CFN200020, EXP Nov. 2022

Other Recalls from AuroMedics Pharma LLC

Recall # Classification Product Date
D-0013-2023 Class II Acyclovir Sodium Injection, 500mg/10mL (50mg/mL... Sep 26, 2022
D-1551-2022 Class III Tranexamic Acid Injection, USP, 1000mg per 10 m... Sep 26, 2022
D-0556-2022 Class I Polymyxin B for Injection USP, 500,000 Units pe... Jan 26, 2022
D-0248-2021 Class II Acetaminophen Injection 1,000 mg per 100 mL (10... Dec 30, 2020
D-0853-2020 Class III Glycopyrrolate Injection, USP 4 mg per 20 mL (0... Feb 7, 2020

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.